KRAS and pancreatic neoplasm: Expression of a dominant negative K-ras gene, K-rasS17N, was performed by transient transfection of two pancreatic cancer cell lines with endogenous K-ras mutations, Panc1 (Figure 1E) and SU86.86 [11].